Pharming Group N.V. Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities
Pharming Group N.V. (PHAR) reported Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities of -$43.67 million for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-03.
Financial Statements › Cash Flow › Operating Activities
ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities · last filed 2025-04-03
EUR
| Period end | Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2020-12-31 | 3.31M EUR 20-F · filed 2021-04-07 |
USD
| Period end | Increase Decrease Through Obtaining Or Losing Control Of Subsidiaries Or Other Businesses Liabilities Arising From Financing Activities 12 month |
|---|---|
| 2024-12-31 | -$43.67M 20-F · filed 2025-04-03 |
| 2023-12-31 | $1.29M 20-F · filed 2024-04-04 |
| 2022-12-31 | $16.08M 20-F · filed 2023-04-05 |
| 2021-12-31 | $14.12M 20-F · filed 2022-04-06 |